BINV - ETF AI Analysis
Top Page
Brandes International ETF (BINV)
Rating:58Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown strong gains over the year and in recent months, indicating positive momentum for investors.
Broad International Diversification
Holdings spread across many countries, including the USA, Europe, and Asia, help reduce the impact of problems in any single market.
Defensive Sector Tilt
Meaningful exposure to consumer defensive and health care companies can provide some stability during market downturns.
Negative Factors
Relatively High Expense Ratio
The fund’s fees are on the higher side for an ETF, which can slightly reduce the net returns investors receive over time.
Weak Performance in Several Top Holdings
Some of the largest positions, including major technology and consumer names, have recently lagged, which can drag on overall results.
Heavy U.S. Weight in an International Fund
A large portion of assets is still tied to the USA, which may limit the pure international diversification that some investors are seeking.
BINV vs. SPDR S&P 500 ETF (SPY)
AUM543.03M
RegionGlobal
Expense Ratio0.70%
Beta0.60
IssuerBrandes
Inception DateOct 03, 2023
Dividend Yield2.05%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume37,756
30 Day Avg. Volume39,421
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
51.96Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering66
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BINV Summary
Brandes International ETF (BINV) is an actively managed fund that invests in value-priced stocks from around the world, with no specific index but a focus on the total international market. It holds companies from the U.S., Europe, and Asia, including well-known names like SAP and Alibaba, as well as major healthcare and consumer brands. Investors might consider BINV if they want global diversification and believe undervalued companies can grow over time. However, because it owns stocks from many countries and sectors, its price can go up and down with both global markets and currency swings.
How much will it cost me?The Brandes International ETF (BINV) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because it is actively managed, meaning experts are selecting stocks rather than following a passive index.
What would affect this ETF?The Brandes International ETF (BINV) could benefit from global economic recovery and increased consumer spending, particularly in sectors like Consumer Defensive and Health Care, which are heavily weighted in its portfolio. However, it may face challenges from rising interest rates or geopolitical tensions that could impact international markets and the performance of its top holdings, such as Sanofi and Alibaba. Additionally, regulatory changes in emerging markets could pose risks to some of its investments.
BINV Top 10 Holdings
BINV leans heavily on international value names, with Europe and Asia doing most of the talking. On the positive side, consumer staples like Henkel and Heineken are quietly pulling the fund forward, while health-care names such as Takeda and Fresenius add a steady, defensive backbone. On the flip side, big holdings in Alibaba and SAP have been lagging, acting like a brake on recent returns, and Sanofi has also lost some steam. Overall, the ETF is diversified across sectors but notably anchored in non-U.S. defensive and value plays.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| SAP SE | 3.22% | $17.42M | $239.90B | -27.40% | 69 Neutral | |
| Alibaba | 2.96% | $16.02M | $302.57B | 11.53% | 68 Neutral | |
| Sanofi | 2.89% | $15.64M | €90.34B | -7.54% | 75 Outperform | |
| Takeda Pharmaceutical Co | 2.37% | $12.85M | ¥8.84T | 21.73% | 66 Neutral | |
| Henkel AG & Co. KGaA | 2.29% | $12.41M | €31.05B | 14.83% | 73 Outperform | |
| Heineken Holding NV | 2.07% | $11.19M | €20.17B | 20.35% | 76 Outperform | |
| Wal-Mart de Mexico SAB de CV | 2.00% | $10.82M | $863.07B | -5.54% | ― | |
| Diageo | 1.98% | $10.75M | $53.78B | -12.94% | 60 Neutral | |
| Astellas Pharma | 1.93% | $10.43M | $26.32B | 36.07% | ― | |
| Reckitt Benckiser Group | 1.91% | $10.35M | $45.53B | -6.10% | 78 Outperform |
BINV Technical Analysis
Positive
―
Price Trends
43.14
Positive
42.41
Positive
41.38
Positive
Market Momentum
0.80
Negative
71.28
Negative
86.06
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BINV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 44.41, equal to the 50-day MA of 43.14, and equal to the 200-day MA of 41.38, indicating a bullish trend. The MACD of 0.80 indicates Negative momentum. The RSI at 71.28 is Negative, neither overbought nor oversold. The STOCH value of 86.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BINV.
BINV Peer Comparison
Comparison Results
Performance Comparison
BINV
Brandes International ETF
45.65
9.33
25.69%
GMOI
GMO International Value ETF
―
―
―
FPAG
FPA Global Equity ETF
―
―
―
MFSV
MFS Active Value ETF
―
―
―
COPY
Tweedy Browne Insider + Value ETF Trust Units
―
―
―
CSTK
Invesco Comstock Contrarian Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents